Transcriptional dysregulation and impaired neuronal activity in FMR1 knock-out and Fragile X patients iPSC-derived models.
Gilles MaussioniD, Cecilia Rocha, Narges AbdianiD, Dimitri YangiD, J TurkiD, Dulce Carrillo Valenzuela, Luisa S.B. PimenteliD, Zhipeng You, Barbara Morquette, Michaël NicouleauiD, Éric DeneaultiD, Samuel Higgins, Carol X.‐Q. CheniD, Wolfgang ReintschiD, SK Ho, Vincent SoubannieriD, Sarah LépineiD, Zora D. ModrusaniD, Jessica M. Lund, William StephensoniD, Rajib SchubertiD, Thomas M. DurcaniD
Abstract
The lack of fragile X mental retardation protein (FMRP) protein, due to a repression of the FMR1 gene, causes Fragile X syndrome (FXS), one of the most prevalent forms of syndromic autisms. The FMR1 gene codes for an RNA binding protein involved in the regulation of gene expression through RNA processing, control of local translation, and protein-protein interactions; processes that are crucial for proper brain development. Taking advantage of induced pluripotent stem cells (iPSCs) and CRISPR-Cas9 genome editing technologies, we generated iPSC-derived cortical neural progenitors and cortical neurons from an FMR1 knock-out and patient cell line with the aim of identifying common phenotypes between the two cellular models. Using RNA sequencing, quantitative PCR and multielectrode array approaches, we assessed how the absence of the functional FMR1 gene affects the transcriptional profiles and the activities of iPSC-derived cortical neuronal progenitor cells (NPCs) and neurons with both models. We observed that FMR1 KO and FXS patient cells have a decrease in their mean firing rate; a cellular activity that can also be blocked by tetrodotoxin (TTX) application in wild-type active neurons. Relative to wild-type neurons, in FMR1 KO neurons, increased expression of presynaptic mRNA and transcription factors involved in the forebrain specification and decreased levels of mRNA coding AMPA and NMDA subunits were observed. Intriguingly, 40% of the differentially expressed genes were commonly deregulated between NPCs and differentiating neurons with significant enrichments in FMRP targets and Autism Related Genes found amongst downregulated genes. This implies that an absence of functional FMRP affects transcriptional profiles at the NPC stage, resulting in impaired activity and differentiation of the progenitors into mature neurons over time. These findings from the FMR1 KO lines were also shared with FXS patients iPSC-derived cells that also present with an impairment in activity and neuronal differentiation, illustrating the critical role of FMRP protein in neuronal development.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 15
- FWCI
- 2.49
- Field percentile
- top 10%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Novel fragile X syndrome 2D and 3D brain models based on human isogenic FMRP-KO iPSCs
Carlo Brighi, Federico Salaris, … Silvia Di Angelantonio·Cell Death and DiseasePeer-reviewed·May 15, 2021
- An iPSC model of fragile X syndrome reflects clinical phenotypes and reveals m6A-mediated epi-transcriptomic dysregulation underlying synaptic dysfunction
Lu Lu, Avijite Kumer Sarkar, … Ziyuan Guo·bioRxiv·Oct 14, 2024
- Integrative analysis identifies key molecular signatures underlying neurodevelopmental deficits in Fragile X Syndrome
Kagistia Hana Utami, Niels Henning Skotte, … Mahmoud A. Pouladi·Biological PsychiatryPeer-reviewed·May 13, 2020
- Partial FMRP expression is sufficient to normalize neuronal hyperactivity in Fragile X neurons
John D. Graef, Hao Wu, … Owen B. Wallace·European Journal of NeurosciencePeer-reviewed·Dec 26, 2019
- FMR1 reduction alters cellular and circuit properties in human cortex
Aditi Singh, Saman Abbaspoor, … Emily K. Osterweil·bioRxiv·Mar 12, 2026
- Identification of FMRP target genes expressed in corticogenesis: implication for common phenotypes among neurodevelopmental disorders
Cristine R. Casingal, Takako Kikkawa, … Noriko Osumi·bioRxiv·Sep 18, 2019